| Net income | -100K |
| Loss (income) from discontinued operations, net of income taxes | 200K |
| Depreciation and amortization | 45.9M |
| Amortization of debt discount and financing costs | 1.7M |
| Stock compensation | 7.7M |
| (Gain) loss in debt repurchased and bank amendment | |
| Accounts receivable | 22.2M |
| Inventories | -1M |
| Grantor trust | |
| Other receivables, prepaid expenses and other | |
| Income tax receivable | |
| Real estate held for entitlement and leasing | |
| Other noncurrent assets | -12.3M |
| Accounts payable | 11.5M |
| Pension benefits | |
| Postretirement medical and life benefits | -33.1M |
| Advance payments on contracts | -26.9M |
| Other current liabilities | |
| Deferred income taxes | 9.2M |
| Other noncurrent liabilities | -1.7M |
| Net cash provided by continuing operations | |
| Net cash used in discontinued operations | |
| Net Cash Provided by Operating Activities | 48.9M |
| Purchases of investments with restricted cash | |
| Sales of investments with restricted cash | |
| Purchases of marketable securities | |
| Sales of marketable securities | |
| Capital expenditures | -30.5M |
| Net Cash Provided by (Used in) Investing Activities | -30M |
| Proceeds from the issuance of debt | 500M |
| Debt issuance costs | -3.7M |
| Debt repayments | -595.3M |
| Vendor financing payments | |
| Net Cash Used in Financing Activities | -98.1M |
| Net Increase in Cash and Cash Equivalents | -79.2M |
| Cash and Cash Equivalents at Beginning of Period | 208.5M |
| Cash and Cash Equivalents at End of Period | 129.3M |
| Capital leases | |
| Capital expenditure purchased with a note payable | |